References
- Bang IY, Whang SW, Kim JW, Kim SY, Park CS. 2003. Screening of fungal strains producing lovastatin, an antihyper-cholesterolemic agent. Korean J Food Sci Technol 35: 442-446
- Demain AL. 1999. Pharmaceutically active secondary metabolites of microorganism. Appl Microbiol Biotechnol 52: 455-463 https://doi.org/10.1007/s002530051546
- Stryer L. 1995. Biosynthesis of membrane lipids and steroids. In Biochemistry. W. H. Freeman & Company, New York. Vol 4, p 685-712
- Ha TY, Cho IJ, Lee SH. 1998. Screening of HMG-CoA reductase inhibitory activity of ethanol and methanol extract from cereals and regumes. Korean J Food Sci Technol 30: 224-229
- Slater E, Macdonald E, James S. 1888. Mechanism of action and biological profile of HMG-CoA reductase inhibitors. Drugs 36: 72-82 https://doi.org/10.2165/00003495-198800363-00016
- Finkelstein DB, Ball C. 1992. Biotechnology of filamentous fungi. Butterworth-Heineman, London, UK. p 241-251
- Michael H. 2002. A multiple-dose pharmacodynamic, safety, and pharmacokinetic comparison of extended and immedia- rereleasa formulations of lovastatin. Clinical Therapeutica 24: 112-125 https://doi.org/10.1016/S0149-2918(02)85009-3
- Alberts AW, Chen J, Kuron G, Hunt V, Hoffman C, Rothrock J, Lopez M, Joshua H, Hairris E, Patchett A, Monaghan R, Currie S, Stapley E, Alberts-Schonberg G, Hensens O, Hirshchfield J, Hoogsteen K, Springer J. 1980. Mevinolin: a highly potent competitive inhibitor of 3-hydroxy- 3-methylglutaryl-coenzyme A reductase and a cholesterol-lowing agent. Proc Natl Acad Sci 77: 3957-3961 https://doi.org/10.1073/pnas.77.7.3957
- Endo A. 1985. Compactin (ML-236B) and related compound as potential cholesterol-lowing agent that inhibit HMGCoA reductase. J Med Chem 28: 401-405 https://doi.org/10.1021/jm00382a001
- Tobert JA. 1988. Efficacy and long-term adverse effect pattern of lovastatin. J American Cardiology 62: 28-34 https://doi.org/10.1016/0002-9149(88)90004-5
- Endo A, Kuroda M, Tarazawa K. 1976. Competitive inhibitor of 3-hydoxy-methylglutaryl-coenzyme A reductase by MC-230A and ML-236B fungal metabolites having hypocholesterolemic activity. FEBS Lett 72: 323-326 https://doi.org/10.1016/0014-5793(76)80996-9
- Srinivasu MK, Narasa RA, Om RG. 2002. Determination of lovastatin and simvastatin in pharmaceutical dosage forms by MEKC. J Pharm Biomed Anal 29: 715-721 https://doi.org/10.1016/S0731-7085(02)00128-0
- Park JH, Kim HS. 2004. Production of lovastatin in solid culture. J Korean Soc Food Sci Nutr 33: 566-570 https://doi.org/10.3746/jkfn.2004.33.3.566
- Pyo YH. 2006. Optimum conditions for production of mevinolin from the soybean fermented with Monascus sp.. Korean J Food Sci Technol 38: 256-261
- Valera HR, Gomes J, Lakshmi S, Guruaja R, Suryanarayan S, Kumar D. 2005. Lovastatin production by solid state fermentation using Aspergillus flavipes. Enzyme Microb Tecchnol 37: 521-526 https://doi.org/10.1016/j.enzmictec.2005.03.009
- Hucher FH, Oleson WH. 1973. Simplified spectrophotometrin for microsomal 3-hydroxy-3-methylglutaryl CoA reductase by measurement of coenzyme A. J Lipid Res 14: 625-631
- Moon YJ, Yeum KH, Sung CK. 2002. Screening of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor in vitro and its application to pullets. Korean J Food Nutr 15: 307-313
- Park JH. 2006. A study of mass production and industrialization of lovastatin from Aspergillus terreus ATCC 20542 mutant. PhD Dissertation. Keimyung University, Daegu. p 58
- Lee JW, Lee SM, Gwak KS, Lee JY, Choi IG. 2006. Screening of edible mushrooms for the production of lovastatin and its HMG-CoA reductase inhibitory activity. Korean J Microbiol 42: 83-88
Cited by
- Antioxidant Activities and Monacolin K Production on Solid-State Fermentation of Diverse Yam by Aspergillus Species Strain vol.50, pp.1, 2014, https://doi.org/10.7845/kjm.2014.4004
- Anti-Diabetic Effect of Red Ginseng-Chungkukjang with Green Laver or Sea Tangle vol.15, pp.3, 2010, https://doi.org/10.3746/jfn.2010.15.3.176